Figure 1
From: Prognostic value of X-chromosome inactivation in symptomatic female carriers of dystrophinopathy
Dystrophin immunostaining in muscle biopsy sections from representative symptomatic carriers . A) D/BMD-like subject #3, B) severe BMD-like subject #4, C) severe BMD-like subject #6, D) severe BMD-like subject #8, E) mild BMD-like subject #13, F) subject #19 presenting mild mental retardation but no muscle weakness. No association was found between dystrophin abnormalities and clinical phenotype.